Rocket Pharmaceuticals, Inc. (RCKT) Ownership

$12.35

south_east
-$0.21 (-1.67%)
Day's range
$12.32
Day's range
$12.94

Rocket Pharmaceuticals, Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
RTW INVESTMENTS, LP 02/14/2025 17.69 M $222.34 M   0.00% 18.79%
WELLINGTON MANAGEMENT GROUP LLP 02/12/2025 14.00 M $175.92 M   24.49% 14.86%
BLACKROCK FUNDING, INC. /DE 02/07/2025 7.10 M $89.21 M   11.40% 7.54%
VANGUARD GROUP INC 02/11/2025 6.58 M $82.68 M   18.79% 6.99%
MAVERICK CAPITAL LTD 02/14/2025 5.20 M $65.35 M   26.23% 5.52%
WESTFIELD CAPITAL MANAGEMENT CO LP 02/11/2025 4.71 M $59.26 M   4.91% 5.01%
JANUS HENDERSON GROUP PLC 02/14/2025 4.00 M $50.34 M   111.03% 4.25%
PRICE T ROWE ASSOCIATES INC /MD/ 02/14/2025 3.15 M $39.58 M   -1.85% 3.34%
SUVRETTA CAPITAL MANAGEMENT, LLC 02/14/2025 2.57 M $32.27 M   100.00% 2.73%
GEODE CAPITAL MANAGEMENT, LLC 02/12/2025 1.75 M $22.04 M   8.35% 1.86%
POINT72 ASSET MANAGEMENT, L.P. 02/14/2025 1.57 M $19.73 M   3,163.94% 1.67%
FRAZIER LIFE SCIENCES MANAGEMENT, L.P. 02/18/2025 1.48 M $18.59 M   -0.44% 1.57%
02/14/2025 1.47 M $18.43 M   100.00% 1.56%
PICTET ASSET MANAGEMENT HOLDING SA 02/12/2025 1.32 M $16.57 M   -4.96% 1.40%
AVORO CAPITAL ADVISORS LLC 02/14/2025 1.20 M $15.08 M   100.00% 1.27%
TORONTO DOMINION BANK 02/19/2025 1.10 M $13.83 M   100.00% 1.17%
NOVO HOLDINGS A/S 02/14/2025 1.10 M $13.83 M   0.00% 1.17%
PROSIGHT MANAGEMENT, LP 02/14/2025 1.09 M $13.69 M   583.14% 1.16%
AVIDITY PARTNERS MANAGEMENT LP 02/14/2025 1.05 M $13.24 M   40.63% 1.12%
BIOIMPACT CAPITAL LLC 02/14/2025 1.02 M $12.83 M   -4.30% 1.08%
GOLDMAN SACHS GROUP INC 02/11/2025 802,785 $10.09 M   89.30% 0.85%
RUSSELL INVESTMENTS GROUP, LTD. 02/13/2025 791,877 $9.95 M   -2.52% 0.84%
EVENTIDE ASSET MANAGEMENT, LLC 02/14/2025 770,691 $9.69 M   0.00% 0.82%
DIMENSIONAL FUND ADVISORS LP 02/13/2025 760,941 $9.56 M   -16.62% 0.81%
TANG CAPITAL MANAGEMENT LLC 02/14/2025 750,000 $9.43 M   0.00% 0.80%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 02/06/2025 656,090 $8.25 M   15.14% 0.70%
FRANKLIN RESOURCES INC 02/12/2025 653,559 $8.22 M   -62.23% 0.69%
WOODLINE PARTNERS LP 02/14/2025 652,421 $8.20 M   8.54% 0.69%
SIREN, L.L.C. 02/14/2025 600,000 $7.54 M   100.00% 0.64%
UBS GROUP AG 02/14/2025 569,963 $7.16 M   68.56% 0.61%
JPMORGAN CHASE & CO 02/12/2025 515,528 $6.48 M   -7.37% 0.55%
MARSHALL WACE, LLP 02/13/2025 456,762 $5.74 M   4,422.40% 0.49%
VOSS CAPITAL, LLC 02/13/2025 421,700 $5.30 M   100.00% 0.45%
SCHRODER INVESTMENT MANAGEMENT GROUP 02/12/2025 413,550 $4.98 M   75.98% 0.44%
PRIVIUM FUND MANAGEMENT B.V. 02/11/2025 397,650 $5.00 M   34.89% 0.42%
M28 CAPITAL MANAGEMENT LP 02/13/2025 385,680 $4.85 M   0.00% 0.41%
PERCEPTIVE ADVISORS LLC 02/14/2025 378,584 $4.76 M   -59.37% 0.40%
INVESCO LTD. 02/13/2025 357,840 $4.50 M   1.48% 0.38%
MILLENNIUM MANAGEMENT LLC 02/14/2025 336,909 $4.23 M   -71.98% 0.36%
SPHERA FUNDS MANAGEMENT LTD. 02/14/2025 271,792 $3.42 M   17.26% 0.29%
SOLEUS CAPITAL MANAGEMENT, L.P. 02/14/2025 271,659 $3.41 M   100.00% 0.29%
STEMPOINT CAPITAL LP 02/14/2025 270,983 $3.41 M   100.00% 0.29%
HENNION & WALSH ASSET MANAGEMENT, INC. 01/15/2025 237,499 $2.99 M   7.44% 0.25%
BARCLAYS PLC 02/13/2025 233,952 $2.94 M   50.96% 0.25%
IKARIAN CAPITAL, LLC 02/14/2025 221,911 $2.79 M   12.59% 0.24%
WALLEYE CAPITAL LLC 02/13/2025 220,142 $2.77 M   59.06% 0.23%
RENAISSANCE TECHNOLOGIES LLC 02/13/2025 218,519 $2.75 M   100.00% 0.23%
ADAR1 CAPITAL MANAGEMENT, LLC 02/13/2025 211,400 $2.66 M   4,816.28% 0.22%
OVATA CAPITAL MANAGEMENT LTD 02/13/2025 200,000 $2.51 M   100.00% 0.21%
BANK OF NEW YORK MELLON CORP 02/04/2025 194,182 $2.44 M   5.40% 0.21%

Rocket Pharmaceuticals, Inc. institutional Ownership - FAQ's

During the previous two years, 262 institutional investors and hedge funds held shares of Rocket Pharmaceuticals, Inc.. The most heavily invested institutionals were:

RTW INVESTMENTS, LP: 17.69 M

WELLINGTON MANAGEMENT GROUP LLP: 14 M

BlackRock Funding, Inc. /DE: 7.1 M

VANGUARD GROUP INC: 6.58 M

MAVERICK CAPITAL LTD: 5.2 M

WESTFIELD CAPITAL MANAGEMENT CO LP: 4.71 M

116.45% of Rocket Pharmaceuticals, Inc. stock is owned by institutional investors.

Institutional investors have bought a total of 248.68 M shares in the last 24 months. This purchase volume represents approximately $3.07 B in transactions.